Výsledky vyhledávání - "Dirk Osterkorn"

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease

Autor: Tobias Pflederer, Harduin Reeg, Klaus Osterkorn, Reinhard Hettich, Reinhard Klingel, Dirk Osterkorn, Norbert Lotz, Franz Heigl

Publikováno v: Clinical Research in Cardiology Supplements

Low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp(a)) are established causal risk factors for cardiovascular disease (CVD). Efficacy, safety, and tolerability of lipoprotein apheresis (LA) were investigated in 118 patients with CVD c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df49a3ec011fbba5cb831118acac71c
https://doi.org/10.1007/s11789-015-0071-3

Zobrazit plný text záznamu

Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European prospective multicenter observational postauthorization safety study (PASS)

Autor: Dirk Osterkorn, Franz-Josef Kretz, Robert Sümpelmann, Robert Luntzer, Ralf Gäbler, Wilhelm Alexander Osthaus, Michaela Carina Haeger, Simone Baroncini

Publikováno v: Pediatric Anesthesia. 18:929-933

Summary Background: Several clinical studies have shown that hydroxyethyl starch (HES) may be as effective and safe as, but less expensive than, albumin when used for perioperative plasma volume replacement (PVR) in children. The new third generation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ab3b01b906b7dad4fa1034adaea414
https://doi.org/10.1111/j.1460-9592.2008.02696.x

Zobrazit plný text záznamu

Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany

Autor: Tobias Pflederer, Franz Heigl, Dirk Osterkorn, Reinhard Klingel, Norbert Lotz, Klaus Osterkorn, Harduin Reeg, Reinhard Hettich

Publikováno v: Atherosclerosis. Supplements. 18

LDL cholesterol (LDL-C) and lipoprotein(a) (Lp(a)) are main risk factors for cardiovascular disease (CVD). Efficacy, safety, and tolerability of lipoprotein apheresis (LA) were investigated in 36,745 LA treatments of 118 patients with CVD in a retros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11712270444b8ace28700ce48557ef98
https://pubmed.ncbi.nlm.nih.gov/25936320

Zobrazit plný text záznamu

Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients

Autor: Dirk Osterkorn, Reinhard Hettich, Martin Canis, Christian W. Luebbers, Franz Heigl, Klaus Osterkorn, M. Suckfuell

Publikováno v: Atherosclerosis. Supplements. 10(5)

Background Sudden sensorineural hearing loss (SSHL) may be caused by a reduction of cochlear perfusion. Cholesterol and fibrinogen negatively influence rheological properties of blood thus leading to alteration of microcirculation. Fibrinogen/LDL aph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53dd64646a2dd319edfe41663d7c5c9
https://pubmed.ncbi.nlm.nih.gov/20129384

Zobrazit plný text záznamu

Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children

Autor: Robert Sümpelmann, Lars Witt, Meike Brütt, Dirk Osterkorn, Wilhelm Alexander Osthaus, Wolfgang Koppert

Publikováno v: Paediatric anaesthesia. 20(1)

INTRODUCTION A balanced volume replacement strategy is a well established concept for correcting hypovolemia using plasma adapted isotonic crystalloid solutions with a physiological electrolyte pattern and acetate as bicarbonate precursor. Recently,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abb8f43bcb117cdd6401a8c8a6124eb
https://pubmed.ncbi.nlm.nih.gov/19968805

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání